TKNO
NASDAQ
$5.13
Alpha Teknova Inc (TKNO)
Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology sector, specializing in the production of vital biological reagents and supplements that cater to life sciences research and biomanufacturing. The company's offerings play a pivotal role in high-demand areas such as vaccine development, cell and gene therapy, and diagnostic testing, underscored by a commitment to quality and exceptional customer service. With a robust biotechnology foundation and a strong focus on innovation, Alpha Teknova is well-equipped to capitalize on growth opportunities in the rapidly evolving life sciences market, positioning itself as a valuable investment for institutional stakeholders.
Sector:
Healthcare
Buy
Target: $9 (+75.44%)
Market Cap
$214M
Free Cash Flow Yield
-4.23%
Beta (5Y)
1.46
Price Chart
Valuation
Market Cap$214M
P/S5.98
P/B3.85
Profitability
Total Revenue (TTM)$42M
Gross Profit (TTM)$14M
EBITDA-$9.97M
Profit Margin-41.1%
Operating Margin-38.8%
EPS-$0.32
Financial Health
Debt-to-Equity20.3%
Free Cash Flow Yield-4.23%
Growth & Risk
Beta (5Y)1.46
Sharpe Ratio0.19